The stock price of Mannkind Corp (NASDAQ: MNKD) has dropped by -1.57 compared to previous close of 3.81. Despite this, the company has seen a fall of -4.34% in its stock price over the last five trading days. globenewswire.com reported 2025-06-09 that MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Session
Is It Worth Investing in Mannkind Corp (NASDAQ: MNKD) Right Now?
Mannkind Corp (NASDAQ: MNKD) has a price-to-earnings ratio that is above its average at 37.61x. The stock has a 36-month beta value of 1.00. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MNKD is 294.46M, and at present, short sellers hold a 8.42% of that float. On June 18, 2025, the average trading volume of MNKD was 2.03M shares.
MNKD’s Market Performance
MNKD stock saw a decrease of -4.34% in the past week, with a monthly decline of -14.19% and a quarterly a decrease of -28.02%. The volatility ratio for the week is 2.48%, and the volatility levels for the last 30 days are 3.26% for Mannkind Corp (MNKD). The simple moving average for the last 20 days is -9.00% for MNKD’s stock, with a simple moving average of -34.58% for the last 200 days.
Analysts’ Opinion of MNKD
Many brokerage firms have already submitted their reports for MNKD stocks, with Mizuho repeating the rating for MNKD by listing it as a “Outperform.” The predicted price for MNKD in the upcoming period, according to Mizuho is $12 based on the research report published on April 10, 2025 of the current year 2025.
Wedbush, on the other hand, stated in their research note that they expect to see MNKD reach a price target of $11. The rating they have provided for MNKD stocks is “Outperform” according to the report published on February 10th, 2025.
Wells Fargo gave a rating of “Overweight” to MNKD, setting the target price at $9 in the report published on December 20th of the previous year.
MNKD Trading at -15.92% from the 50-Day Moving Average
After a stumble in the market that brought MNKD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.85% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MNKD starting from Binder Steven B., who sale 64,085 shares at the price of $4.00 back on Jun 10 ’25. After this action, Binder Steven B. now owns 925,258 shares of Mannkind Corp, valued at $256,340 using the latest closing price.
STEVEN B BINDER, the Director of Mannkind Corp, proposed sale 64,085 shares at $4.00 during a trade that took place back on Jun 10 ’25, which means that STEVEN B BINDER is holding shares at $256,430 based on the most recent closing price.
Stock Fundamentals for MNKD
Current profitability levels for the company are sitting at:
- 0.26 for the present operating margin
- 0.75 for the gross margin
The net margin for Mannkind Corp stands at 0.1. The total capital return value is set at 0.26.
Based on Mannkind Corp (MNKD), the company’s capital structure generated -4.16 points at debt to capital in total, while cash flow to debt ratio is standing at 0.62. The debt to equity ratio resting at -0.81. The interest coverage ratio of the stock is 1.97.
Currently, EBITDA for the company is 77.47 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 3.83. The receivables turnover for the company is 10.3for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.36.
Conclusion
To sum up, Mannkind Corp (MNKD) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
